A detailed history of Vanguard Group Inc transactions in Vaxart, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 10,077,418 shares of VXRT stock, worth $6.25 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
10,077,418
Previous 9,950,952 1.27%
Holding current value
$6.25 Million
Previous $6.67 Million 28.47%
% of portfolio
0.0%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$0.58 - $0.99 $73,350 - $125,201
126,466 Added 1.27%
10,077,418 $8.57 Million
Q2 2024

Aug 13, 2024

BUY
$0.53 - $1.3 $795,842 - $1.95 Million
1,501,590 Added 17.77%
9,950,952 $6.67 Million
Q1 2024

May 10, 2024

BUY
$0.56 - $1.41 $786,458 - $1.98 Million
1,404,391 Added 19.93%
8,449,362 $11 Million
Q4 2023

Feb 14, 2024

BUY
$0.57 - $0.85 $50,234 - $74,911
88,131 Added 1.27%
7,044,971 $4.02 Million
Q3 2023

Nov 14, 2023

BUY
$0.69 - $0.85 $43,082 - $53,073
62,439 Added 0.91%
6,956,840 $5.22 Million
Q2 2023

Aug 14, 2023

SELL
$0.6 - $1.41 $101,691 - $238,973
-169,485 Reduced 2.4%
6,894,401 $5.03 Million
Q1 2023

May 15, 2023

BUY
$0.71 - $1.25 $31,509 - $55,473
44,379 Added 0.63%
7,063,886 $5.37 Million
Q4 2022

Feb 10, 2023

BUY
$0.75 - $2.24 $23,562 - $70,371
31,416 Added 0.45%
7,019,507 $6.74 Million
Q3 2022

Nov 14, 2022

BUY
$2.09 - $4.5 $715,779 - $1.54 Million
342,478 Added 5.15%
6,988,091 $15.2 Million
Q2 2022

Aug 12, 2022

BUY
$2.7 - $5.28 $1.54 Million - $3.01 Million
570,707 Added 9.39%
6,645,613 $23.3 Million
Q1 2022

May 13, 2022

BUY
$4.29 - $6.64 $387,266 - $599,406
90,272 Added 1.51%
6,074,906 $30.6 Million
Q4 2021

Feb 14, 2022

SELL
$5.77 - $7.96 $8,856 - $12,218
-1,535 Reduced 0.03%
5,984,634 $37.5 Million
Q3 2021

Nov 12, 2021

BUY
$6.67 - $9.8 $768,710 - $1.13 Million
115,249 Added 1.96%
5,986,169 $47.6 Million
Q2 2021

Aug 13, 2021

BUY
$5.06 - $10.78 $29.7 Million - $63.3 Million
5,870,920 New
5,870,920 $44 Million

Others Institutions Holding VXRT

About Vaxart, Inc.


  • Ticker VXRT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 126,506,000
  • Market Cap $78.4M
  • Description
  • Vaxart, Inc., a clinical-stage biotechnology company, engages in the discovery and development of oral recombinant protein vaccines based on its proprietary oral vaccine platform. The company's product pipeline includes norovirus vaccine, an oral tablet vaccine, which is in a Phase Ib clinical trial with bivalent oral tablet vaccine for the GI.1...
More about VXRT
Track This Portfolio

Track Vanguard Group Inc Portfolio

Follow Vanguard Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.